Amyotrophic lateral sclerosis (ALS) is a late-onset, fatal disorder in which motor neurons selectively degenerate. Superoxide dismutase 1 (SOD1) was found to be a causative gene of familial ALS, and mutant SOD1 transgenic mice recapitulated ALS phenotypes. Analysis of these mice showed accumulation of misfolded SOD1 protein in motor neurons. Misfolded SOD1 accumulation was found in spinal motor neurons of both familial ALS patients with the SOD1 mutation and sporadic ALS patients. However, it is unclear what condition causes wild-type SOD1 misfolding in patients without the SOD1 mutation. Here, we generated induced pluripotent stem cells from mutant SOD1 transgenic mice, wild-type SOD1 transgenic mice, and control mice, and differentiated them into spinal motor neurons to analyze misfolded SOD1 accumulation. We found that misfolded SOD1 protein was accumulated in spinal motor neurons of both mutant and wild-type SOD1 transgenic mice as detected by a specific antibody against the misfolded conformation of SOD1. These results suggest that an increased expression level of wild-type SOD1 may accelerate the ALS pathology and that our in vitro model would be a useful tool for misfolded SOD1 research. NeuroReport 29:25-29
Introduction
Amyotrophic lateral sclerosis (ALS) is a devastating disorder in which progressive motor neuronal degeneration leads to muscle weakness, respiratory failure, and death within as short as several years [1, 2] . The precise pathomechanism of ALS is still unknown, and effective treatment has not been established. Genetic analysis of ALS patients identified superoxide dismutase 1 (SOD1) as a causative gene of familial ALS in 1993 [3] and mutant SOD1 transgenic mice were established as a well-recapitulated ALS model [4] . Analysis of these SOD1 transgenic mice developed understandings of ALS, and showed that accumulated SOD1 protein was misfolded in spinal motor neurons.
SOD1 protein is considered to gain a toxic function by its misfolding [5] and misfolded SOD1 is highly observed in mutant SOD1 transgenic mouse spinal cord [6, 7] . Many previous studies have presented molecular mechanisms of SOD1 toxicity in ALS pathology including excitotoxicity, oxidative stress, mitochondrial dysfunction, axonal transport, and non-cell autonomous toxicity [8, 9] . In contrast, misfolded SOD1 protein accumulation was reported not only in familial ALS patients with SOD1 mutation but also in sporadic ALS patients by histopathological analysis of postmortem tissues [10] . However, it is unclear why misfolded SOD1 accumulations are found in spinal motor neurons without the SOD1 mutation. Here, we analyzed misfolded SOD1 protein accumulation with sensitivity-different antibodies using induced pluripotent stem cell (iPSC)-derived spinal motor neurons, and found that overexpression of wildtype SOD1 causes its misfolding.
Materials and methods

Transgenic animals
This animal study was approved by our institutional review board. Wild-type SOD1 transgenic mice (B6.CgTg(SOD1)2Gur/J) or mutant SOD1 transgenic mice (B6SJL-Tg(SOD1*G93A)1Gur/J) were obtained from the Jackson Laboratory (Bar Harbor, Maine, USA).
Induced pluripotent stem cell generation iPSCs were generated from mouse embryonic fibroblasts (MEFs) of wild-type SOD1 transgenic mice, mutant SOD1 transgenic mice, and nontransgenic mice. Four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc) were introduced into the MEFs using retroviral vectors as reported previously [11, 12] . iPSCs were cultured on SNL feeder cells.
RT-PCR
RNA was isolated with Trizol (Thermo Fisher Scientific, Waltham, Massachusetts, USA), and first-strand cDNA was synthesized using the PrimeScript RT reagent Kit (Takara Bio, Kusatsu, Japan). RT-PCR was performed using ExTaq (Takara Bio). Primer sets are listed in Supplementary Table S1 (Supplemental digital content 1, http://links.lww.com/WNR/A443).
In vitro differentiation to three germ layers
The iPSCs were trypsinized into single cells and plated on Petri dishes (Kord-Valmark, Brampton, Ontario, Canada) to form embryoid bodies (EBs) as reported previously [13] . After 3 days, they were transferred to gelatincoated dishes and cultured for another 3 days. Cells were fixed and stained with anti-β-III tubulin (1 : 500; Millipore, Billerica, Massachusetts, USA), anti-α-smooth muscle actin (1 : 100; Dako, Glostrup, Denmark), or anti-α-fetoprotein (1 : 500; R&D Systems, Minneapolis, Minnesota, USA) antibodies.
Differentiation to spinal motor neurons iPSCs were differentiated into motor neurons according to the methods described previously [14, 15] . iPSCs were trypsinized into single cells, then resuspended in DM1 medium (DMEM/F12) (Thermo Fisher Scientific), 10% knockout serum (Thermo Fisher Scientific), penicillin, streptomycin, glutamine (Thermo Fisher Scientific) and 2-mercaptoethanol (Thermo Fisher Scientific), and plated at a concentration of 200 000 cells/ml in Petri dishes to form EBs. After 48 h, EBs were divided from one dish into four Petri dishes containing DM1 medium supplemented with 1 μM retinoic acid (Sigma-Aldrich, St Louis, Missouri, USA) and 1 μM Smoothened agonist (Enzo Life Sciences, Farmingdale, New York, USA). On day 7, the EBs were dissociated into single cells using papain and DNase, resuspended into MN medium containing DMEM/F12, 5% horse serum (Thermo Fisher Scientific), B-27 supplement (Thermo Fisher Scientific), N2 supplement (Thermo Fisher Scientific), neurotrophic factors [GDNF, CNTF, NT3, and BDNF: 10 ng/ml (Peprotech, Princeton, New Jersey, USA], and penicillin/ streptomycin (Thermo Fisher Scientific), and then replated at a concentration of 1.5 × 10 5 /cm 2 onto poly-Dlysine/laminin-coated plates. Two-thirds of the medium was changed every 3 days.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (pH 7.4) for 30 min at room temperature and rinsed with PBS. The cells were permeabilized in PBS containing 0.2% Triton X-100 for 10 min at room temperature, followed by rinsing with PBS. Nonspecific binding was blocked with PBS containing 10% donkey serum for 60 min at room temperature. Cells were incubated with primary antibodies overnight at 4°C and then labeled with appropriate fluorescently tagged secondary antibodies. 4′,6-Diamidino-2-phenylindole (Nacalai Tesque, Kyoto, Japan) was used to label nuclei. Fluorescence images were obtained using a BZ-9000 fluorescence microscope 
Statistical analysis
All data were shown as mean SEM. Results were analyzed using one-way analysis of variance, followed by Tukey's post-hoc test to determine statistical significances of the data. A P-value less than 0.05 was considered statistically significant. Analyses were carried out using IBM SPSS statistics software (IBM Corp., Armonk, New York, USA).
Results
Generation of induced pluripotent stem cells and spinal motor neuron differentiation iPSCs were generated from MEFs of mutant SOD1 transgenic mice (SOD1 G93A), wild-type SOD1 transgenic mice (SOD1 WT), and nontransgenic mice (control) (Fig. 1a) . These generated iPSCs expressed embryonic stem cell markers (Fig. 1b) . Pluripotency of these iPSCs was confirmed by an in vitro three-germ layer assay (Fig. 1c) , and generated iPSCs showed normal karyotypes (Fig. 1d ).
iPSCs were differentiated into spinal motor neurons (Fig. 2a) . The generated spinal motor neurons were immunostained by motor neuron markers Hb9, Isl1, and pan-neuron marker β-III tubulin on day 11 (Fig. 2b) .
Evaluation of misfolded SOD1 protein in spinal motor neurons
We evaluated the accumulation of misfolded SOD1 in spinal motor neurons using two misfolded SOD1-specific antibodies with different epitopes; A5C3 recognizes 80-118 amino acids of SOD1 and B8H10 recognizes 57-78 amino acids of SOD1 [8] . SOD1 G93A motor neurons were clearly immunostained by one of the misfolded SOD1-specific antibodies (A5C3), whereas SOD1 WT motor neurons and control motor neurons were not immunostained by that antibody. The other misfolded Neural stem cell marker nestin was stained on day 9 and motor neuron markers Hb9 and Isl1 were stained on day 11. Scale bar = 100 μm. EB, embryoid body; iPSC, induced pluripotent stem cell.
SOD1 antibody (B8H10) clearly stained both SOD1 WT motor neurons and SOD1 G93A motor neurons, but did not stain control motor neurons ( Fig. 3a and b) . Our results suggested that misfolded SOD1 antibodies with different epitopes showed different sensitivity to misfolded SOD1 protein and overexpression of wild-type SOD1 presented protein misfolding in spinal motor neurons as well as mutant SOD1 overexpression.
Discussion
We generated iPSCs from mutant SOD1 transgenic mice, wild-type SOD1 transgenic mice, and non-transgenic mice, and evaluated the accumulation of misfolded SOD1 protein using iPSC-derived spinal motor neurons. We found that overexpression of wild-type SOD1 caused protein misfolding as well as mutant SOD1, and antibody sensitivity to misfolded SOD1 protein differed depending on the epitopes.
It has been suggested that TDP-43, another important molecule in ALS, might more generally be involved in ALS pathology, and ALS caused by the SOD1 mutation has been considered a separate entity from general ALS [17] . However, accumulation of misfolded SOD1 protein was Detection of misfolded SOD1 in iPSC-derived motor neurons. (a) Immunostaining of motor neurons on day 21. SOD1 G93A motor neurons distinguished by choline acetyltransferase staining were clearly immunolabeled by a misfolded-specific anti-SOD1 monoclonal antibody (A5C3), whereas SOD1 wild-type (WT) motor neurons and control motor neurons had less immunoreactivity (upper panels). The other misfolded-specific anti-SOD1 monoclonal antibody (B8H10) showed immunoreactivity to SOD1 G93A motor neurons and SOD1 WT motor neurons (lower panels). Scale bar = 100 μm. (b) Quantification of misfolded SOD1-positive neurons. The misfolded SOD1-positivity in SOD1 G93A motor neurons was higher than in SOD1 WT motor neurons or control motor neurons by evaluation with the misfolded SOD1 antibody (A5C3). Each group represents mean SEM, n = 3 wells, with each nine fields images; *P < 0.05, one-way analysis of variance, followed by Tukey's multiple comparison post-hoc test. The misfolded SOD1-positivity in SOD1 G93A motor neurons or SOD1 WT motor neurons was higher than that in control motor neurons by evaluation with the misfolded SOD1 antibody (B8H10). Each group represents mean SEM, n = 3 wells, with each providing nine image fields; *P < 0.05, oneway analysis of variance, followed by Tukey's multiple comparison post-hoc test.
reported in sporadic ALS patients without the SOD1 mutation [10] . This suggested the contribution of misfolding of wild-type SOD1 toward the pathogenesis of sporadic ALS.
Previous studies have presented the toxic effects of wildtype SOD1 in vivo. Old mice expressing heterozygous wildtype SOD1 showed a loss of motor neurons in the spinal cord, although the life span was not affected [4] . Further, homozygous wild-type SOD1 transgenic mice developed ALS-like symptoms and had a short life span [18] . Wild-type SOD1 transgenic mice also showed exacerbated disease caused by mutant SOD1 [19] [20] [21] . These reports indicated that increased expression levels of wild-type SOD1 may accelerate the ALS pathology. Although it has not yet been shown how structural loosening is caused as a post-translational modification by the overexpression of SOD1, our in vitro model would be a useful tool to analyze the pathogenesis of misfolded SOD1-mediated ALS.
